Recaída de la púrpura trombocitopénica inmune tras la vacunación frente al SARS-CoV-2

García Ramírez, Patricia; Castilla García, Lucía; Aspa Cilleruelo, José María.
Med. clín (Ed. impr.) ; 158(10): 497-498, mayo 2022. ilus
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-204559

Documentos relacionados

  1. Pathogenesis of refractory ITP: Overview.
  2. An update on pediatric ITP: differentiating primary ITP, IPD, and PID.
  3. Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review.
  4. Role of interleukin 4 (IL4) and interleukin 6 (IL6) in the pathogenesis and prognosis of childhood primary immune thrombocytopenia.
  5. Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response.
  6. Utilization of an ITP quality improvement pathway improves adherence to management guidelines.
  7. Binge-reading on immune thrombocytopenia: Everything you ever wanted to know.
  8. Vaccinations and ITP: keep on track(ing).
  9. Arepally GM, Ortel TL. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. Blood. 2021;138(4):293-298.
  10. Clinical significance of antinuclear antibodies in primary immune thrombocytopenia.